Gene · 287
ANK2: ankyrin 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ANK2: ankyrin 2. Genes, record 287. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/287
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q01484 | Ankyrin-2 | 3,957 | 11 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37419 | Q01484 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7329 | Q01484 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7329 | Q01484 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4859 | Q01484 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 224 | Q01484 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 4859 | Q01484 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 107830 | Q01484 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 217854 | Q01484 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 217854 | Q01484 | Espacenet |
| JP 2016519285 A | 2016-06-30 | 224 | Q01484 | Espacenet |
1 to 10 of 19
See all 19 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,548
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANK2 papers | Newest fiscal year |
|---|---|---|---|
| R01MH107182 | Postsynaptic roles of ankyrins | 6 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 4 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 4 | 2025 |
| R01HL092577 | IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL | 4 | 2025 |
| R01HL131517 | Sex-specific arrhythmogenic mechanisms of atrial fibrillation | 4 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 4 | 2025 |
| T32HG002295 | Training in Bioinformatics and Integrative Genomics | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,548Source NIH's project files
See all 1,548 nih grantsPapers1,566
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal Characterization of Giant ANK2-Depleted Monkeys Suggests Neurodevelopmental-Disorder-Like Phenotypes. | Research (Wash D C) | 2026 | 42707610 | PubTator, text mining | PubMed |
| Prenatal diagnosis of a familial 4q26 duplication encompassing the genes of ANK2, MYOZ2 and USP53 associated with asymptomatic carrier members in the family. | Taiwan J Obstet Gynecol | 2026 | 42642122 | PubTator, text mining | PubMed |
| Molecular determinants of functional voltage-gated sodium (Nav) channel diversity in mammalian central neurons. | J Physiol | 2026 | 42555659 | PubTator, text mining | PubMed |
| High-degree atrioventricular block in a child with an ANK2 variant and long QT phenotype requiring leadless pacemaker implantation. | Cardiol Young | 2026 | 42493853 | PubTator, text mining | PubMed |
| Subcortical Dendritic Scaffolding in Autism Spectrum Disorder: A Testable ANK2-SCN2A-SHANK Framework. | Int J Mol Sci | 2026 | 42450246 | PubTator, text mining | PubMed |
| Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters. | J Cardiovasc Aging | 2026 | 42369572 | PubTator, text mining | PubMed |
| A human corticospinal organoid-slice connectoid model informs enhancer strategies for post-injury axon regrowth. | Cell Rep | 2026 | 42201810 | PubTator, text mining | PubMed |
| Comprehensive Pathologic and Genetic Investigation of Four Young Adults with a Short QT Interval and Sudden Unexpected Death. | J Mol Diagn | 2026 | 42092729 | PubTator, text mining | PubMed |
| Metabolic-Epigenetic Crosstalk in Takayasu Arteritis: The ANK2-MAVS-IL-8 Axis as a Novel Therapeutic Paradigm. | Int J Mol Sci | 2026 | 41977430 | PubTator, text mining | PubMed |
| miR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression. | Endokrynol Pol | 2026 | 41972507 | PubTator, text mining | PubMed |
1 to 10 of 1,566
See all 1,566 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/287
GET https://conductscience.org/api/genes/v1/287/patents